<DOC>
	<DOCNO>NCT00444418</DOCNO>
	<brief_summary>The purpose study study effectiveness medication specialize psychotherapy help gay bisexual men want quit drinking learn reduce drink healthy level . More information study available www.projectsmartnyc.org .</brief_summary>
	<brief_title>Medication Counseling Controlled Drinking ( Project SMART )</brief_title>
	<detailed_description>Problem drinking gay bisexual men try quit drinking risk relapse heavy problematic drink social life social outlet often strongly associate alcohol . These men receptive intervention focus moderation drink rather abstinence . However moderation-oriented cognitive-behavior therapy ( CBT ) naltrexone ( NTX ) well establish treatment problem drinker wish moderate , rather stop , drink . Research suggest combine treatment may enhance efficacy . This study combine moderation-oriented CBT NTX treatment problem drinking gay bisexual men , wish abstain alcohol , evaluate efficacy alone combination . We also propose utilize new data collection technology , Interactive Voice Response , collect data daily relation among drinking , sexual behavior psychological variable think mediate treatment response . Our objective evaluate efficacy 12 week randomly assign treatment , 100 mg NTX placebo , combine brief supportive therapy modify , behavioral self-control therapy specifically tailor gay/bisexual men ; evaluate conditional relationship heavy drinking likelihood HIV risk behavior ; evaluate daily association among mood , crave , self-efficacy , motivation , drinking . Assessments include baseline , 3 , 6 , &amp; 9 month follow-up . A substudy treatment trial conduct collect bank sample blood research aim associate naturally occur difference DNA patient response NTX , potential mediational mechanism action NTX . Information gather gene gene product may use conjunction data clinical psychological factor obtain part clinical trial evaluate relationship among genetic variant , drug effect , mechanism treatment response . Patients ask give blood sample Week 0 clinical trial purpose carry genetic research .</detailed_description>
	<mesh_term>Alcoholism</mesh_term>
	<mesh_term>Alcohol Drinking</mesh_term>
	<mesh_term>Alcohol-Related Disorders</mesh_term>
	<mesh_term>Naltrexone</mesh_term>
	<criteria>Males 1865 year old Currently sexually active men Report drinking level substantially excess establish guideline nonhazardous drink Willing reduce drink nonhazardous level English literate ( 8th grade level ) Current physical disease condition make participant inappropriate medication trial , include total bilirubin elevation &gt; 110 % , AST ALT elevation &gt; 300 % . History serious psychiatric illness ( psychotic disorder , bipolar disorder , psychiatric illness require hospitalization ) , current psychiatric illness ( major depression posttraumatic stress disorder ) require treatment currently untreated , serious risk suicidal violent behavior Recent ( past three month ) initiation psychotropic medication psychotherapy , recent change psychotropic medication treatment Current DSMIV diagnosis drug ( nicotine ) dependence , lifetime diagnosis opioid dependence DSMIV alcohol dependence diagnosis judge clinically severe , history present evidence significant alcohol withdrawal symptom , recurrent use alcohol alleviate withdrawal Regular use opioids past month History hypersensitivity NTX Considered study physician suitable receipt investigational drug Likely require treatment opiate pain medication course study</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>April 2013</verification_date>
	<keyword>Drinking</keyword>
	<keyword>Alcohol problem</keyword>
	<keyword>Alcoholism</keyword>
	<keyword>Gay men</keyword>
	<keyword>Bisexual men</keyword>
	<keyword>Moderation-oriented treatment</keyword>
	<keyword>Controlled drinking</keyword>
	<keyword>Non-abstinence base treatment</keyword>
</DOC>